• Auven Therapeutics SA

    LU
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-100.3.819.723-9
    Sector: Operation of other financial institutions

    Age of the company

    8 months

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Auven Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Auven Therapeutics SA

    • Auven Therapeutics SA in Luzern is a Company limited by shares (AG) from the sector «Operation of other financial institutions». Auven Therapeutics SA is active.
    • The company was founded on 27.09.2024 and has 5 persons in its management.
    • Under «Notifications» you will find all commercial register changes, the most recent one was made on 06.03.2025.
    • The Enterprise Identification Number of the company Auven Therapeutics SA is the following: CHE-499.592.014.

    Commercial register information

    Source: SOGC

    Sector

    Operation of other financial institutions

    Purpose (Original language)

    Der Zweck der Gesellschaft ist der Erwerb, das Halten, die Finanzierung und der Verkauf von Beteiligungen an anderen Unternehmen jedwelcher Art in der Schweiz oder im Ausland. Die Gesellschaft kann im In- und Ausland Zweigniederlassungen und Tochterunternehmen errichten, Vertretungen übernehmen sowie jegliche Geschäftstätigkeiten ausüben und Verträge jeglicher Art abschliessen, die dem Gesellschaftszweck förderlich sein können oder die direkt oder indirekt mit dem Gesellschaftszweck in Zusammenhang stehen. Sie kann Grundstücke im In- und Ausland erwerben, halten, belasten und verkaufen mit Ausnahme von Geschäften, die durch das Bundesgesetz über den Erwerb von Grundstücken durch Personen im Ausland (BewG) untersagt sind. Die Gesellschaft kann bei der Verfolgung ihres Gesellschaftszwecks die Interessen ihrer direkten und indirekten Aktionäre berücksichtigen. Insbesondere kann die Gesellschaft ihren direkten und indirekten Tochtergesellschaften sowie Dritten, einschliesslich ihren direkten und indirekten Aktionären sowie deren direkten und indirekten Tochtergesellschaften, Darlehen und andere direkte oder indirekte Finanzierungen gewähren, einschliesslich im Rahmen von Cash-Pooling-Vereinbarungen, und für deren Verbindlichkeiten Sicherheiten aller Art stellen, einschliesslich mittels Pfandrechten an oder fiduziarischen Übereignungen von Aktiven der Gesellschaft oder Garantien jedwelcher Art, ob entgeltlich oder nicht.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • Auven Therapeutics AG
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Newest SOGC notifications: Auven Therapeutics SA

    SOGC 250306/2025 - 06.03.2025
    Categories: Debt call to creditors

    Publication number: SR01-0000013008, Commercial Registry Office Zug

    Category: Other calls to creditors issued under company law Sub-category: Call to creditors following the merger of companies limited by shares under MergA Publication date: SHAB 06.03.2025, Repeated Publication: 04.03.2025, 05.03.2025 Publicly viewable until: 06.03.2028 Publication number: Publishing entity Raima Sherifoska, Luzernerstrasse 3, 6343 Rotkreuz Commissioned by: Auven Therapeutics SA Rigistrasse 28

  • Lucerne Call to creditors following the merger of companies limited by shares acc. MerA C.T. Phinco S.à r.l., en liquidation volontaire with Auven Therapeutics SA
  • Publication Transferrring organisation: C.T. Phinco S.à r.l., en liquidation volontaire 28, Boulevard F.W. Raiffeisen 2411 Luxemburg Luxembourg Acquiring organisation: Auven Therapeutics SA CHE-499.592.014 Rigistrasse 28 6006 Luzern Announcement of merger in SOGC: 23.12.2024 Legal notice: Call to creditors following merger (Art. 25 para. 2 MerA). The creditors of all legal entities involved in the merger can, within the stated time limit, demand that their claims are satisfied or secured. Time limit: 23.03.2025 (Three months after the merger takes legal effect)
    Point of contact: Auven Therapeutics SA Rigistrasse 28
  • Luzern

  • SOGC 250305/2025 - 05.03.2025
    Categories: Debt call to creditors

    Publication number: SR01-0000013005, Commercial Registry Office Zug

    Category: Other calls to creditors issued under company law Sub-category: Call to creditors following the merger of companies limited by shares under MergA Publication date: SHAB 05.03.2025, Repeated Publication: 04.03.2025, 06.03.2025 Publicly viewable until: 05.03.2028 Publication number: Publishing entity Raima Sherifoska, Luzernerstrasse 3, 6343 Rotkreuz Commissioned by: Auven Therapeutics SA Rigistrasse 28

  • Lucerne Call to creditors following the merger of companies limited by shares acc. MerA C.T. Phinco S.à r.l., en liquidation volontaire with Auven Therapeutics SA
  • Publication Transferrring organisation: C.T. Phinco S.à r.l., en liquidation volontaire 28, Boulevard F.W. Raiffeisen 2411 Luxemburg Luxembourg Acquiring organisation: Auven Therapeutics SA CHE-499.592.014 Rigistrasse 28 6006 Luzern Announcement of merger in SOGC: 23.12.2024 Legal notice: Call to creditors following merger (Art. 25 para. 2 MerA). The creditors of all legal entities involved in the merger can, within the stated time limit, demand that their claims are satisfied or secured. Time limit: 23.03.2025 (Three months after the merger takes legal effect)
    Point of contact: Auven Therapeutics SA Rigistrasse 28
  • Luzern

  • SOGC 250304/2025 - 04.03.2025
    Categories: Debt call to creditors

    Publication number: SR01-0000013002, Commercial Registry Office Zug

    Category: Other calls to creditors issued under company law Sub-category: Call to creditors following the merger of companies limited by shares under MergA Publication date: SHAB 04.03.2025, Repeated Publication: 05.03.2025, 06.03.2025 Publicly viewable until: 04.03.2028 Publication number: Publishing entity Raima Sherifoska, Luzernerstrasse 3, 6343 Rotkreuz Commissioned by: Auven Therapeutics SA Rigistrasse 28

  • Lucerne Call to creditors following the merger of companies limited by shares acc. MerA C.T. Phinco S.à r.l., en liquidation volontaire with Auven Therapeutics SA
    1. Publication Transferrring organisation: C.T. Phinco S.à r.l., en liquidation volontaire 28, Boulevard F.W. Raiffeisen 2411 Luxemburg Luxembourg Acquiring organisation: Auven Therapeutics SA CHE-499.592.014 Rigistrasse 28 6006 Luzern Announcement of merger in SOGC: 23.12.2024 Legal notice: Call to creditors following merger (Art. 25 para. 2 MerA). The creditors of all legal entities involved in the merger can, within the stated time limit, demand that their claims are satisfied or secured. Time limit: 23.03.2025 (Three months after the merger takes legal effect)

    Point of contact: Auven Therapeutics SA Rigistrasse 28
  • Luzern

  • Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm